In brief, our study implied that the GAL1 protein is highly associated with oncological outcomes of UTUC by promoting tumor invasion, metastasis, and epithelial–mesenchymal transition, possibly through the FAK/PI3K/AKT/mTOR pathway (Figure 7). The gene discussed is PTK2; the disease is renal pelvis/ureter urothelial carcinoma.